METROPOLIS HEALTHCARE
|
|
BOM : 542650     NSE : METROPOLIS     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Jun 09,2025 |
Price(EOD): ₹ 1,717.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 8,896.13 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
METROPOLIS HEALTHCARE | 0.2% | 3% | -12.7% |
MAX HEALTHCARE INSTITUTE | 4.8% | 6% | 49.2% |
APOLLO HOSPITALS ENTERPRISE | 1.8% | 3.2% | 18.8% |
FORTIS HEALTHCARE | 5.1% | 15.3% | 74.4% |
GLOBAL HEALTH | -1.7% | 2.4% | 13.3% |
NARAYANA HRUDAYALAYA | 2.2% | 0.6% | 50.6% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -3% | 3.2% | 78.8% |
DR LAL PATHLABS | 1.7% | 3.5% | 7.8% |
ASTER DM HEALTHCARE | 3.1% | 7.3% | 74.8% |
FUNDAMENTAL ANALYSIS OF METROPOLIS HEALTHCARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF METROPOLIS HEALTHCARE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
61.14
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 145.51 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] 6.68
P/B Calculated based on Book Value of Rs 1,330.97 Cr
[Latest Year - Mar2025 - Consolidated Results ] 6.68
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,331.20 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
7% -17% -19% |
SHARE PRICE MOMENTUM OF METROPOLIS HEALTHCARE
METROPOLIS HEALTHCARE vs SENSEX
DEBT OF METROPOLIS HEALTHCARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0.09 0.31 0.13 |
0 0.08 0.3 0.13 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF METROPOLIS HEALTHCARE
Pledged Promoter Shares |
1.18 % | |
---|---|---|
As on : Mar2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF METROPOLIS HEALTHCARE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
6.98% -13.49% -14.86% -7.13% |
4.32% -22.11% -28.67% -19.97% |
QtrlyTrend |
-4 | |
Latest Qtr: Mar2025 | ||
Quarterly Result Analysis → |
METROPOLIS HEALTHCARE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
BSE 250 SMALLCAP INDEX | 3.2% | 14.7% | 9.1% |
BSE 400 MIDSMALLCAP INDEX | 3% | 12.2% | 8.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP250 MOMENTUM QUALITY 100 INDEX | 3.9% | 15.3% | 1.5% |
NIFTY SMALLCAP 250 | 3.3% | 15.4% | 9.8% |
NIFTY MIDSMALLCAP 400 | 3.2% | 13.1% | 10% |
NIFTY SMALLCAP250 QUALITY 50 | 3.1% | 16.7% | 12.2% |
NIFTY 500 EQUAL WEIGHT | 2.8% | 13.3% | 8.2% |
You may also like the below Video Courses
FAQ about METROPOLIS HEALTHCARE
Is METROPOLIS HEALTHCARE good for long term investment?
As on Jun 09,2025, the Fundamentals of METROPOLIS HEALTHCARE look Strong and hence it may be good for long term investment! See Financial Performance of METROPOLIS HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is METROPOLIS HEALTHCARE UnderValued or OverValued?
As on Jun 09,2025, METROPOLIS HEALTHCARE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of METROPOLIS HEALTHCARE ?
As on Jun 09,2025, the Intrinsic Value of METROPOLIS HEALTHCARE is Rs. 2,063.61 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,599.49
Fair Value [Median EV / Sales Model] : Rs. 2,063.61
Fair Value [Median Price / Sales Model] : Rs. 2,129.71
Estimated Median Fair Value of METROPOLIS HEALTHCARE : Rs. 2,063.61
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.